Literature DB >> 9862278

Homocysteine and ischaemic heart disease in the Caerphilly cohort.

J B Ubbink1, A M Fehily, J Pickering, P C Elwood, W J Vermaak.   

Abstract

Elevated circulating total homocyst(e)ine concentrations are associated with a higher prevalence of ischaemic heart disease (IHD). We utilized data from the Caerphilly Prospective Cohort Study to assess the predictive power of the serum total homocyst(e)ine concentration for future IHD. Serum total homocyst(e)ine concentrations were measured in 2290 men in the Caerphilly cohort, a representative population sample of men aged 50-64 years. During a 5-year follow-up period, 56 men suffered fatal IHD, 77 had a non-fatal myocardial infarction, while 21 were found to have ECG evidence of myocardial infarction (MI) when examined at follow-up. The mean serum total homocyst(e)ine concentration in the total of 154 men who experienced an incident IHD event was 12.4 micromol/l, whereas the 2136 men who experienced no such event had a mean level of 11.7 micromol/l. The difference between these means, examined by logistic regression and standardising for the effects of differences in age, social class, smoking, BMI, diabetes, HDL-cholesterol and prevalent IHD is 0.47 micromol/l (95% CI = -0.13 to 1.11 micromol/l). The mean difference for the 56 men who died, and whose death was attributed to IHD, is 0.81 micromol/l (95% CI= -0.17 to 1.88 micromol/l) after correction for confounding factors. Vitamin nutritional status and alcohol intake were significant negative determinants of serum total homocyst(e)ine concentrations; the effect of alcohol is explained by the folic acid content of beer, which is the preferred alcoholic beverage in Caerphilly. It is concluded that the serum total homocyst(e)ine concentration is weakly predictive of IHD events, though in the present data adjustments for other factors attenuated the relationship and it became not statistically significant (P > 0.05).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862278     DOI: 10.1016/s0021-9150(98)00139-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

Review 1.  Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults.

Authors:  Cynthia M Carlsson
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Homocysteine and ischaemic stroke in men: the Caerphilly study.

Authors:  U B Fallon; P Elwood; Y Ben-Shlomo; J B Ubbink; R Greenwood; G D Smith
Journal:  J Epidemiol Community Health       Date:  2001-02       Impact factor: 3.710

3.  Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up.

Authors:  U B Fallon; Y Ben-Shlomo; P Elwood; J B Ubbink; G D Smith
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

4.  Homocysteine and long-term recurrent infarction following an acute coronary syndrome.

Authors:  Gema Miñana; Carolina Gil-Cayuela; Lorenzo Fácila; Vicent Bodi; Ernesto Valero; Anna Mollar; Maria Marco; Teresa García-Ballester; Begoña Zorio; Jorge Martí-Cervera; Eduardo Núñez; Francisco J Chorro; Juan Sanchis; Julio Núñez
Journal:  Cardiol J       Date:  2020-12-21       Impact factor: 2.737

5.  Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.

Authors:  G L Booth; E E Wang
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

6.  The Hordaland Homocysteine Studies.

Authors:  P M Ueland; O Nygård; S E Vollset; H Refsum
Journal:  Lipids       Date:  2001       Impact factor: 1.880

Review 7.  Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk.

Authors:  Elisabetta Trabetti
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

8.  Fasting total homocysteine (tHcy) concentration and mortality in older Mexican Americans.

Authors:  V Colon Lopez; M N Haan; A E Aiello; D Ghosh
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

9.  Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease.

Authors:  Mohammad A Alam; Syed A Husain; Rajiv Narang; Shayam S Chauhan; Madhulika Kabra; Suman Vasisht
Journal:  Mol Cell Biochem       Date:  2007-12-12       Impact factor: 3.396

10.  Alcohol increases homocysteine and reduces B vitamin concentration in healthy male volunteers--a randomized, crossover intervention study.

Authors:  A Gibson; J V Woodside; I S Young; P C Sharpe; C Mercer; C C Patterson; M C McKinley; L A J Kluijtmans; A S Whitehead; A Evans
Journal:  QJM       Date:  2008-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.